Literature DB >> 16421666

Advances in the use of tocols as drug delivery vehicles.

Panayiotis P Constantinides1, Jihong Han, Stanley S Davis.   

Abstract

There has been increasing interest in recent years in the drug delivery applications of tocols and their derivatives. Their biocompatibility and potential to deliver both poorly soluble and water-soluble drugs make tocols attractive as drug delivery vehicles. This review article will focus primarily on topical, oral, and parenteral drug administration using tocols, although other routes of delivery such as pulmonary and nasal will also be discussed. After an overview of the tocol structures, physicochemical properties with emphasis on their solvent properties, functions, and metabolism, specific case studies will be discussed where tocols have been successfully used in topical, oral, and parenteral drug formulations and marketed drug products. Case studies will be extended to those where tocol-based formulations were administered pulmonarily and nasally. As more clinical data and marketed drug products emerge, the utility and therapeutic value of tocols will certainly increase.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16421666     DOI: 10.1007/s11095-005-9262-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  77 in total

Review 1.  Solubilizing excipients in oral and injectable formulations.

Authors:  Robert G Strickley
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

Review 2.  Nanomedicines for overcoming biological barriers.

Authors:  Maria José Alonso
Journal:  Biomed Pharmacother       Date:  2004-04       Impact factor: 6.529

3.  Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol.

Authors:  Hee-Jeong Youk; Eunmyong Lee; Moon-Kyung Choi; Young-Ju Lee; Jun Ho Chung; So-Hee Kim; Chang-Hun Lee; Soo-Jeong Lim
Journal:  J Control Release       Date:  2005-09-20       Impact factor: 9.776

4.  Illness with fatalities in premature infants: association with an intravenous vitamin E preparation, E-Ferol.

Authors:  W J Martone; W W Williams; M L Mortensen; R P Gaynes; J W White; V Lorch; M D Murphy; S N Sinha; D J Frank; N Kosmetatos
Journal:  Pediatrics       Date:  1986-10       Impact factor: 7.124

5.  Preparation and in vitro characterization of HSA-mPEG nanoparticles.

Authors:  W Lin; M C Garnett; E Schacht; S S Davis; L Illum
Journal:  Int J Pharm       Date:  1999-11-05       Impact factor: 5.875

6.  Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A.

Authors:  Hamidreza Montazeri Aliabadi; Abdullah Mahmud; Annahita Dehmoobed Sharifabadi; Afsaneh Lavasanifar
Journal:  J Control Release       Date:  2005-04-08       Impact factor: 9.776

7.  Pre-clinical and clinical evaluation of solution and soft gelatin capsule formulations for a BCS class 3 compound with atypical physicochemical properties.

Authors:  Karen Ramsay-Olocco; Ludmila Alexandrova; Ranjani Nellore; Robert Killion; Li Li; Patricia Coen; Quynh Ho; Donald Jung; Cynthia Rocha
Journal:  J Pharm Sci       Date:  2004-09       Impact factor: 3.534

8.  Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability, applied to cyclosporine.

Authors:  Johanna Mercke Odeberg; Peter Kaufmann; Karl Gunnar Kroon; Peter Höglund
Journal:  Eur J Pharm Sci       Date:  2003-12       Impact factor: 4.384

9.  Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol.

Authors:  R V Cooney; A A Franke; P J Harwood; V Hatch-Pigott; L J Custer; L J Mordan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

10.  Polysorbate 80 and E-Ferol toxicity.

Authors:  S L Alade; R E Brown; A Paquet
Journal:  Pediatrics       Date:  1986-04       Impact factor: 7.124

View more
  21 in total

1.  A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles.

Authors:  Olcay Mert; Samuel K Lai; Laura Ensign; Ming Yang; Ying-Ying Wang; Joseph Wood; Justin Hanes
Journal:  J Control Release       Date:  2011-09-03       Impact factor: 9.776

2.  An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistance.

Authors:  Jianqin Lu; Wenchen Zhao; Hao Liu; Rebecca Marquez; Yixian Huang; Yifei Zhang; Jiang Li; Wen Xie; Raman Venkataramanan; Liang Xu; Song Li
Journal:  J Control Release       Date:  2014-10-24       Impact factor: 9.776

3.  Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route.

Authors:  Easwaran Ravichandran; Fetweh H Al-Saleem; Denise M Ancharski; Mohammad D Elias; Ajay K Singh; Mohammad Shamim; Yujing Gong; Lance L Simpson
Journal:  Infect Immun       Date:  2007-03-19       Impact factor: 3.441

4.  Effects of an antioxidant protective topical formulation on retinal tissue of UV-exposed rabbits.

Authors:  Silvia Bartollino; Marisa Palazzo; Francesco Semeraro; Barbara Parolini; Ciro Caruso; Francesco Merolla; Germano Guerra; Ciro Costagliola
Journal:  Int Ophthalmol       Date:  2020-01-08       Impact factor: 2.031

5.  α-Tocopherols modify the membrane dipole potential leading to modulation of ligand binding by P-glycoprotein.

Authors:  Sterenn Davis; Benjamin M Davis; Joanna L Richens; Kelly-Ann Vere; Peter G Petrov; C Peter Winlove; Paul O'Shea
Journal:  J Lipid Res       Date:  2015-05-29       Impact factor: 5.922

6.  Nanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapy.

Authors:  Ivan S Alferiev; Radhika Iyer; Jamie L Croucher; Richard F Adamo; Kehan Zhang; Jennifer L Mangino; Venkatadri Kolla; Ilia Fishbein; Garrett M Brodeur; Robert J Levy; Michael Chorny
Journal:  Biomaterials       Date:  2015-02-16       Impact factor: 12.479

7.  Tocopheryl Polyethylene Glycol Succinate as a Safe, Antioxidant Surfactant for Processing Carbon Nanotubes and Fullerenes.

Authors:  Aihui Yan; Annette Von Dem Bussche; Agnes B Kane; Robert H Hurt
Journal:  Carbon N Y       Date:  2007-11       Impact factor: 9.594

8.  Differential pharmacodynamic effects of paclitaxel formulations in an intracranial rat brain tumor model.

Authors:  Rong Zhou; Richard V Mazurchuk; Judith H Tamburlin; John M Harrold; Donald E Mager; Robert M Straubinger
Journal:  J Pharmacol Exp Ther       Date:  2009-10-27       Impact factor: 4.030

9.  Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxel.

Authors:  Jianqin Lu; Yixian Huang; Wenchen Zhao; Yichao Chen; Jiang Li; Xiang Gao; Raman Venkataramanan; Song Li
Journal:  Mol Pharm       Date:  2013-07-11       Impact factor: 4.939

Review 10.  Nanomicellar carriers for targeted delivery of anticancer agents.

Authors:  Xiaolan Zhang; Yixian Huang; Song Li
Journal:  Ther Deliv       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.